A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age
Public ClinicalTrials.gov record NCT00508651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Expanded Phase1/2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-560, A Live, Attenuated Recombinant Parainfluenza Virus Type 3 (PIV3) Vaccine, Administered Intranasally to Healthy Infants 1 to <12 Mos. of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to describe the safety and tolerability of 3 doses of MEDI-560 at 10\^5 TCID50 when administered to children 6 to \< 12 months of age who are HPIV3 (human parainfluenza virus type 3) seronegative at baseline and to infants 1 to \< 3 months of age regardless of baseline serostatus.
Study identification
- NCT ID
- NCT00508651
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 30 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 1 Month to 11 Months
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- Apr 2009 (Actual)
- Completion
- Apr 2009 (Actual)
- Last update posted
- Dec 30, 2011
2007 – 2009
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Investigational Research Program | Bentonville | Arkansas | 72712 | — |
| Arkansas Pediatric Clinic | Little Rock | Arkansas | 72205 | — |
| Madera Family Medical Group | Madera | California | 93637 | — |
| Allergy Medical Group of the North Area | Roseville | California | 95678 | — |
| Miami Children's Hospital | Miami | Florida | 33155 | — |
| Homestead Clinical Research | Naranja | Florida | 33032 | — |
| University of South Florida College of Medicine Department of Pediatrics | Tampa | Florida | 33606 | — |
| Kapiolani Medical Center for Women and Children | Honolulu | Hawaii | 96826-1032 | — |
| Michael W. Simon, M.D. | Lexington | Kentucky | 40503 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| Tufts-New England Medical Center | Boston | Massachusetts | 02111 | — |
| Meridian Clinical Research LLC | Omaha | Nebraska | 68134 | — |
| Children's Lung Specialists Ltd. | Las Vegas | Nevada | 89107 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Duke Health Center- Pickett Road | Durham | North Carolina | 27705 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229-3039 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Oklahoma State University Center for Health Sciences | Tulsa | Oklahoma | 74127 | — |
| St. Luke's Hospital | Bethlehem | Pennsylvania | 18015 | — |
| Belleview Pediactric Assoc. | Pittsburgh | Pennsylvania | 15202 | — |
| Holston Medical Group | Kingsport | Tennessee | 37660 | — |
| Dixie Pediatrics | St. George | Utah | 84790 | — |
| University Physicians Internal Medicine | Huntington | West Virginia | 25701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00508651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 30, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00508651 live on ClinicalTrials.gov.